General merchandise retailer Target (NYSE:TGT) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales ...

Target stock fell Wednesday after it reported another lackluster set of results and named a company lifer as its next chief ...

Dave's member growth and financial performance remain strong, driven by its AI-powered CashAI underwriting. Read why I rate DAVE stock a Hold.

Today, the value of this approach is widely recognised even by most pharmaceutical companies, a number of which – including Sanofi, Roche and Genentech, Bayer, and Merck KgaA – have partnered with ...